XML 89 R79.htm IDEA: XBRL DOCUMENT v3.21.2
EMPLOYEE STOCK COMPENSATION - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Aug. 21, 2012
Mar. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Dec. 31, 2020
May 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unvested options outstanding (in shares)     0   0  
Restricted stock awards and units            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized compensation expense     $ 7.0      
Expense recognition period     2 years 1 month 6 days      
Restricted stock awards and units | Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period     1 year      
Restricted stock awards and units | Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period     5 years      
Stock options | Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period     3 years      
Award expiration period     7 years      
Stock options | Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period     5 years      
Award expiration period     10 years      
Stock Appreciation Rights            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award expiration period 10 years          
Common stock issued upon exercise of SARs (in shares)   305,772        
Tax benefit recognized in connection with exercise of SARs   $ 2.1        
Share-based compensation arrangement by share-based payment award, non-option equity instruments, outstanding, number (in shares)     0 0 1,559,012  
2018 Omnibus Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Maximum number of shares authorized for grant (in shares)           4,417,882
Common stock available under new plan (in shares)     3,221,555